Deerfield Mgmt III, L.P.'s Net Worth

$0

Estimate Recalculated May 19, 2025 08:11PM EST

Who is Deerfield Mgmt III, L.P.

Deerfield Mgmt III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fractyl Health, Inc., RHYTHM PHARMACEUTICALS, INC., XERIS PHARMACEUTICALS INC, REGENXBIO Inc., Editas Medicine, Inc., Shockwave Medical, Inc., AERIE PHARMACEUTICALS INC, ARVINAS INC., Neos Therapeutics, Inc., Avalanche Biotechnologies, Inc., GRAYBUG VISION, INC., Acutus Medical, Inc., Larimar Therapeutics, Inc., Syros Pharmaceuticals, Inc., CytomX Therapeutics, Inc., PROTEON THERAPEUTICS INC, AveXis, Inc., SteadyMed Ltd., aTYR PHARMA INC, LUMOS PHARMA, INC., ALIMERA SCIENCES INC, Homology Medicines, Inc., Oncorus, Inc., Audentes Therapeutics, Inc., and ARS Pharmaceuticals, Inc..

SEC CIK

Deerfield Mgmt III, L.P.'s CIK is 0001610540

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Fractyl Health, Inc.

Investor
Updated Feb 08, 2024
Form 4
-53.40%
-956.06K
Feb 08, 2024
834.25K
Options
Feb 06
Form 3
Feb 01, 2024
Showing 2 results

RHYTHM PHARMACEUTICALS, INC.

Investor
Updated Oct 10, 2017
Form 4
-82.44%
-4.40M
$17.00
Oct 10, 2017
937.01K
Buy-Options
Oct 10
Form 3
Oct 04, 2017
Showing 2 results

XERIS PHARMACEUTICALS INC

Investor
Updated Feb 12, 2019
Form 4
-0.84%
-7.24K
$15.09
-$109.25K
Feb 12, 2019
2.36M
Sale
Feb 08 - Feb 11
Form 4
-1.69%
-14.81K
$15.02
-$222.44K
Feb 07, 2019
2.36M
Sale
Feb 05 - Feb 07
Form 4
-0.79%
-7.04K
$15.12
-$106.45K
Jan 30, 2019
2.38M
Sale
Jan 28 - Jan 29
Form 4
-11.44%
-114.44K
$15.43
-$1.77M
Jan 25, 2019
2.38M
Sale
Jan 23 - Jan 25
Form 4
-19.78%
-615.92K
$15.00
Jun 27, 2018
2.50M
Buy-Options
Jun 25
Form 3
Jun 20, 2018
Showing 6 results

REGENXBIO Inc.

Investor
Updated Sep 22, 2015
Form 4
14.97%
175.00K
$22.00
$1.93M
Sep 22, 2015
1.34M
Purchase
Sep 22
Form 3
Sep 16, 2015
Showing 2 results

Editas Medicine, Inc.

Investor
Updated Feb 08, 2016
Form 4
5.85%
100.00K
$16.00
Feb 08, 2016
1.81M
Purchase
Feb 08
Form 3
Feb 02, 2016
Showing 2 results

Shockwave Medical, Inc.

Investor
Updated Mar 11, 2019
Form 4
-91.02%
-3.47M
$17.00
$170.00K
Mar 11, 2019
342.15K
Buy-Options
Mar 11
Form 3
Mar 06, 2019
Showing 2 results

AERIE PHARMACEUTICALS INC

Investor
Updated Jul 23, 2018
Form 4
Jul 23, 2018
3.89M
Form 3
Jul 23, 2018
5.85M
Showing 2 results

ARVINAS INC.

Investor
Updated Oct 01, 2018
Form 4
-58.79%
-1.76M
$16.00
Oct 01, 2018
1.23M
Buy-Options
Oct 01
Form 3
Sep 26, 2018
Showing 2 results

Neos Therapeutics, Inc.

Investor
Updated Jul 28, 2015
Form 4
-28.97%
-350.00K
$14.49
-$2.50M
Jul 28, 2015
858.33K
Sale
Jul 28
Form 3
Jul 22, 2015
Showing 2 results

GRAYBUG VISION, INC.

Investor
Updated Oct 01, 2020
Form 4
-84.23%
-28.21M
$16.00
Oct 01, 2020
5.28M
Buy-Options
Sep 29
Form 3
Sep 24, 2020
Showing 2 results

Acutus Medical, Inc.

Investor
Updated Jul 05, 2022
Form 4
3.78M
Jul 05, 2022
3.78M
Grant
Jun 30
Form 4
24.68%
1.07M
$14.00
$15.00M
Jul 21, 2021
5.42M
Purchase
Jul 19
Form 4
53.30%
1.51M
$18.00
Aug 12, 2020
4.36M
Purchase
Aug 05 - Aug 10
Form 3
Aug 05, 2020
Showing 4 results

Larimar Therapeutics, Inc.

Investor
Updated Feb 16, 2024
Form 4
35.11%
4.29M
$8.74
$37.50M
Feb 16, 2024
21.23M
Purchase
Feb 16
Form 4
190.58%
11.11M
$3.15
$35.00M
Sep 20, 2022
16.94M
Purchase
Sep 16
Form 4
13.33%
685.71K
$8.75
$6.00M
Jul 02, 2021
5.83M
Purchase
Jun 30
Form 3
Jun 08, 2020
6.09M
Showing 4 results

Syros Pharmaceuticals, Inc.

Investor
Updated Jul 06, 2016
Form 4
23.60%
400.00K
$12.50
Jul 06, 2016
2.10M
Purchase
Jul 06
Form 3
Jun 29, 2016
Showing 2 results

CytomX Therapeutics, Inc.

Investor
Updated Oct 14, 2015
Form 4
194.69%
625.00K
$12.00
Oct 14, 2015
946.02K
Purchase
Oct 14
Form 3
Oct 07, 2015
Showing 2 results

PROTEON THERAPEUTICS INC

Investor
Updated Aug 04, 2017
Form 3
Aug 04, 2017
1.22M
Form 4
-91.79%
-14.03M
$10.00
Oct 27, 2014
1.26M
Buy-Options
Oct 27
Form 3
Oct 21, 2014
Showing 3 results

AveXis, Inc.

Investor
Updated Feb 19, 2016
Form 4
78.88%
986.31K
$20.32
$8.96M
Feb 19, 2016
2.24M
Purchase
Sep 03 - Feb 17
Form 3
Feb 10, 2016
263.82K
Showing 2 results

SteadyMed Ltd.

Investor
Updated Mar 25, 2015
Form 4
1,753.14%
1.20M
$8.50
Mar 25, 2015
1.27M
Purchase
Mar 25
Form 3
Mar 19, 2015
Showing 2 results

aTYR PHARMA INC

Investor
Updated May 13, 2015
Form 4
-88.55%
-3.96M
$14.00
May 13, 2015
511.53K
Buy-Options
May 12
Form 3
May 06, 2015
Showing 2 results

LUMOS PHARMA, INC.

Investor
Updated Jan 08, 2021
Form 4
-16.20%
-151.72K
$22.58
-$3.43M
Jan 08, 2021
784.57K
Sale
Jan 06 - Jan 08
Form 3
Mar 20, 2020
936.17K
Showing 2 results

ALIMERA SCIENCES INC

Investor
Updated Dec 08, 2015
Form 4
5.22%
272.25K
$3.01
$819.58K
Dec 08, 2015
5.88M
Purchase
Dec 04 - Dec 08
Form 4
4.89%
243.25K
$3.00
$729.48K
Dec 03, 2015
5.61M
Purchase
Dec 01 - Dec 03
Form 4
1.49%
73.25K
$2.98
$218.48K
Nov 10, 2015
5.36M
Purchase
Nov 06
Form 4
0.34%
16.54K
$3.00
$49.63K
Nov 03, 2015
5.29M
Purchase
Oct 30
Form 4
1.23%
59.34K
$3.00
$177.76K
Oct 29, 2015
5.27M
Purchase
Oct 27 - Oct 28
Form 4
1.27%
60.36K
$3.00
$181.11K
Oct 26, 2015
5.21M
Purchase
Oct 22 - Oct 26
Form 4
8.92%
390.04K
$2.97
$1.16M
Oct 21, 2015
5.15M
Purchase
Oct 19 - Oct 21
Form 4
7.94%
321.79K
$2.42
$779.95K
Oct 09, 2015
4.76M
Purchase
Oct 07 - Oct 09
Form 3
Oct 09, 2015
4.44M
Form 3
Oct 09, 2015
4.44M
Showing 10 results

Homology Medicines, Inc.

Investor
Updated Jan 31, 2020
Form 4
-100.00%
-518.83K
$15.45
-$8.02M
Jan 31, 2020
4.09M
Sale
Jan 29 - Jan 30
Form 4
-55.21%
-639.51K
$15.69
-$10.04M
Jan 28, 2020
4.61M
Sale
Jan 24 - Jan 28
Form 4
-7.89%
-350.00K
$21.95
-$7.68M
Dec 27, 2019
5.25M
Sale
Dec 24
Form 4
-3.58%
-164.73K
$21.78
-$3.59M
Dec 23, 2019
5.60M
Sale
Dec 19 - Dec 23
Form 4
85.33%
533.33K
$22.50
$12.00M
Apr 15, 2019
5.76M
Purchase
Apr 12
Form 4
-75.03%
-15.70M
$16.00
$10.00M
Apr 04, 2018
5.23M
Buy-Options
Apr 02
Form 3
Mar 27, 2018
Showing 7 results

Oncorus, Inc.

Investor
Updated Dec 30, 2022
Form 4
-11.46%
-336.24K
$0.26
-$88.25K
Dec 30, 2022
2.60M
Sale
Dec 28 - Dec 30
Form 4
-2.44%
-73.38K
$0.27
-$19.90K
Dec 27, 2022
2.93M
Sale
Dec 22 - Dec 27
Form 4
-4.09%
-128.26K
$0.29
-$37.63K
Dec 21, 2022
3.01M
Sale
Dec 19 - Dec 21
Form 4
-0.44%
-13.79K
$0.39
-$5.33K
Dec 15, 2022
3.14M
Sale
Dec 13 - Dec 15
Form 4
10.53%
300.00K
$19.00
$5.70M
Feb 18, 2021
3.15M
Purchase
Feb 17
Form 4
-87.25%
-19.50M
$15.00
Oct 08, 2020
2.85M
Buy-Options
Oct 06
Form 3
Oct 01, 2020
Showing 7 results

Audentes Therapeutics, Inc.

Investor
Updated Jul 25, 2016
Form 4
39.85%
400.00K
$15.00
Jul 25, 2016
1.40M
Purchase
Jul 25
Form 3
Jul 19, 2016
Showing 2 results

ARS Pharmaceuticals, Inc.

Investor
Updated Nov 10, 2022
Form 3
Nov 10, 2022
11.08M
Showing 1 results

Avalanche Biotechnologies, Inc.

Investor
Updated Aug 05, 2014
Form 4
154.59%
1.33M
$20.26
$28.52M
Aug 05, 2014
2.20M
Purchase
Aug 05
Form 3
Jul 30, 2014
Showing 2 results